Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Intrathecal Dexmedetomidine × Dexmedetomidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Pheochromocytoma 1 Pain, Intractable 1 Obesity 1 Non-functioning Pituitary Adenoma 1 Neoplasms 1 Nausea 1 Intrathecal Dexmedetomidine 1 Dyspnea 1 Delirium 1 Death 1

Interventions

Fentanyl 1 Dexmedetomidine 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02861716 2018-04-10

Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery

South Egypt Cancer Institute

Phase 2 Unknown

Intrathecal Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡